Testing effectiveness (Phase 2)Study completedNCT01471665What this trial is testingGSK2190915 Neutrophilic Asthma StudyWho this might be right forAsthma GlaxoSmithKline 14
Large-scale testing (Phase 3)Study completedNCT00643292What this trial is testingA Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear InfectionsWho this might be right forAcute Otitis Media Pfizer 902
Very early researchLooking for participantsNCT06950294What this trial is testingINO300 Therapy in Critically Ill Patients With PneumoniaWho this might be right forCritical IllnessPneumonia Massachusetts General Hospital 34
Early research (Phase 1)Study completedNCT02635672What this trial is testingPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerWho this might be right forNeoplasms Vincerx Pharma, Inc. 110
Post-approval studies (Phase 4)Looking for participantsNCT04713670What this trial is testingComparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori InfectionWho this might be right forH. Pylori Infection National Taiwan University Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT03594058What this trial is testingEvaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)Who this might be right forOveractive Bladder Velicept Therapeutics, Inc. 1,413
Large-scale testing (Phase 3)Study completedNCT02321397What this trial is testingTo Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer PainWho this might be right forMalignant PainNon-malignant Pain Mundipharma Research GmbH & Co KG 155
Testing effectiveness (Phase 2)Study completedNCT03280030What this trial is testingMidostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AMLWho this might be right forAcute Myeloid Leukemia Novartis Pharmaceuticals 67
Large-scale testing (Phase 3)Study completedNCT01984424What this trial is testingGoal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3Who this might be right forHyperlipidemia Amgen 511
Large-scale testing (Phase 3)Ended earlyNCT00766688What this trial is testingEvaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe HypercholesterolemiaWho this might be right forHypercholesterolemia Sanofi 643
Testing effectiveness (Phase 2)Study completedNCT00390221What this trial is testingSafety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple SclerosisWho this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 621
Not applicableStudy completedNCT00517114What this trial is testingProspective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese PatientsWho this might be right forGastroesophageal RefluxLaryngitis Hospital Authority, Hong Kong 200
Large-scale testing (Phase 3)Study completedNCT00328978What this trial is testingSeroquel STACK Study in Schizophrenic or Schizoaffective SubjectsWho this might be right forSchizophreniaSchizoaffective Disorders AstraZeneca 330
Testing effectiveness (Phase 2)Study completedNCT05421078What this trial is testingA Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.Who this might be right forDyslipidemiaHypercholesterolemiaHigh Cholesterol NewAmsterdam Pharma 102
Large-scale testing (Phase 3)Ended earlyNCT01760889What this trial is testingSPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaWho this might be right forSchizophrenia Shire 1
Not applicableNot Yet RecruitingNCT07827170What this trial is testingBacillus Probiotics With Bismuth Quadruple Therapy for Helicobacter Pylori InfectionWho this might be right forHelicobacter Pylori InfectionGastrointestinal DysbiosisAntibiotic-associated Adverse Events Anabio R&D 336
Large-scale testing (Phase 3)Study completedNCT01187966What this trial is testingEfficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's DiseaseWho this might be right forParkinson's Disease Newron Pharmaceuticals SPA 669
Not applicableStudy completedNCT06250634What this trial is testingEsomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori InfectionWho this might be right forHelicobacter Pylori Infection The Third Xiangya Hospital of Central South University 806
Post-approval studies (Phase 4)Study completedNCT01546922What this trial is testingHydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)Who this might be right forAdrenal Insufficiency University Medical Center Groningen 63
Testing effectiveness (Phase 2)Study completedNCT00531050What this trial is testingSafety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and SalmeterolWho this might be right forChronic Obstructive Pulmonary Disease Novartis 27